Abstract |
We hypothesize that endothelin-A receptor stimulation contributes to the elevated blood pressure and superoxide production in endothelin-B receptor-deficient rats on a high salt diet. Experiments were conducted on homozygous endothelin-B-deficient (sl/sl) and wild-type rats (wt) fed a high salt diet (8% NaCl) for 3 weeks. Separate groups were given normal drinking water or water containing the endothelin-A receptor antagonist, ABT-627 (5 mg/kg per day; n = 8-9 in all groups). On a normal salt diet, (sl/sl) rats had a significantly elevated systolic blood pressure compared with wt (138 +/- 3 vs 117 +/- 4 mmHg, respectively; P < 0.05). High salt diet caused a significant increase in systolic blood pressure in (sl/sl) rats compared with wt (158 +/- 2 vs 138 +/- 3 mmHg, respectively; P < 0.05). Endothelin-A receptor blockade decreased systolic blood pressure in (sl/sl) rats on high salt (125 +/- 5 mmHg; P < 0.05 vs without antagonist) without affecting the systolic blood pressure in wt (119 +/- 4 mmHg). Aortic superoxide production ( lucigenin chemiluminescence) and plasma 8-isoprostane were elevated in sl/sl rats and were significantly reduced by endothelin-A receptor blockade in sl/sl, but not in wt rats. These findings suggest that endothelin-1, through the endothelin-A receptor, contributes to salt-induced hypertension and vascular superoxide production in endothelin-B-deficient rats.
|
Authors | Ahmed A Elmarakby, E Dabbs Loomis, Jennifer S Pollock, David M Pollock |
Journal | Journal of cardiovascular pharmacology
(J Cardiovasc Pharmacol)
Vol. 44 Suppl 1
Pg. S7-10
(Nov 2004)
ISSN: 1533-4023 [Electronic] United States |
PMID | 15838363
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Endothelin A Receptor Antagonists
- Endothelins
- Pyrrolidines
- Receptor, Endothelin A
- Receptor, Endothelin B
- Sodium Chloride, Dietary
- Superoxides
- 8-epi-prostaglandin F2alpha
- Dinoprost
- Atrasentan
|
Topics |
- Animals
- Animals, Genetically Modified
- Antihypertensive Agents
(pharmacology)
- Aorta
(drug effects, metabolism, physiopathology)
- Atrasentan
- Blood Pressure
(drug effects)
- Dinoprost
(analogs & derivatives, blood)
- Disease Models, Animal
- Down-Regulation
- Endothelin A Receptor Antagonists
- Endothelins
(blood, urine)
- Hypertension
(chemically induced, drug therapy, metabolism, physiopathology)
- Male
- Pyrrolidines
(pharmacology)
- Rats
- Receptor, Endothelin A
(metabolism)
- Receptor, Endothelin B
(deficiency, genetics, metabolism)
- Sodium Chloride, Dietary
- Superoxides
(metabolism)
- Time Factors
|